Advance of antithrombotic treatment in patients with cerebral microbleed

Area of Science:

• Neurology
• Radiology
• Geriatrics

Background:

• Increasing elderly population and widespread use of antithrombotic agents contribute to rising cerebral microbleed (CMB) detection.
• Cerebral microbleeds (CMB) are indicators of small vessel disease severity and predict hemorrhagic transformation.
• The co-occurrence of CMB and antithrombotic therapy presents a clinical management challenge due to bleeding risks.

Purpose of the Study:

• To review recent advancements in the diagnosis of cerebral microbleeds (CMB).
• To summarize current treatment strategies for patients with cerebral microbleeds (CMB).
• To provide clinical guidance for physicians managing patients with CMB and antithrombotic indications.

Main Methods:

• Literature review of recent studies on cerebral microbleed (CMB) diagnosis.
• Synthesis of current research on antithrombotic therapy in the context of CMB.
• Analysis of clinical decision-making challenges in managing CMB and bleeding risks.

Main Results:

• Emerging MRI sequences enhance CMB detection rates.
• CMB presence necessitates careful consideration of antithrombotic therapy risks versus benefits.
• Clinical practice requires balancing antithrombotic indications against potential bleeding complications.

Conclusions:

• Accurate CMB diagnosis is crucial for risk stratification.
• Personalized treatment strategies are needed for patients with CMB and antithrombotic indications.
• This review serves as a reference for optimizing clinical decisions in managing cerebral microbleeds.